Penumbra
PEN
#1722
Rank
A$18.04 B
Marketcap
A$458.80
Share price
-0.24%
Change (1 day)
16.88%
Change (1 year)
Categories
Penumbra, Inc., is an American company that develops, manufactures and sells medical devices for neurovascular and vascular medicine applications.

Penumbra (PEN) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : A$0.61 Billion

According to Penumbra's latest financial reports the company's total liabilities are A$0.61 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Penumbra - Total liabilities on balance sheet (from 2014 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31A$0.59 B-3.09%
2024-12-31A$0.61 B10.95%
2023-12-31A$0.55 B1.31%
2022-12-31A$0.54 B36.52%
2021-12-31A$0.40 B66.27%
2020-12-31A$0.24 B-6.47%
2019-12-31A$0.25 B95.92%
2018-12-31A$0.13 B34.55%
2017-12-31A$97.68 M68.82%
2016-12-31A$57.86 M34.55%
2015-12-31A$43 M-73.69%
2014-12-31A$0.16 B84.04%
2013-12-31A$88.8 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Merit Medical
MMSI
A$1.58 B 157.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Inari Medical
NARI
A$0.38 B-38.19%๐Ÿ‡บ๐Ÿ‡ธ USA